Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours

Oncogene

Volumn 15, Issue 7, 1997, Pages 871-874

  Chattopadhyay, Parthaprasad ^a   Rathore, Annapurna ^a   Mathur, Meera ^a   Sarkar, Chitra ^a   Mahapatra, Ashok K ^a   Sinha, Subrata ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chromosomes, human, pair 17; Gene, suppressor, tumour; Glioma, genetics

Indexed keywords

PROTEIN P53;

ARTICLE; ASTROCYTOMA; CANCER GENETICS; CANCER GRADING; CHROMOSOME 17P; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE LOCUS; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0030827255     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201238     Document Type: Article

References (16)

1. Carrozzo R and Ledbetter DH. (1993). Hum. Mol. Genet., 2, 615.
2. Frankel RH, Bayona W, Koslow M and Newcomb EW. (1992). Cancer Res., 52, 1427-1433.
3. Fults D, Brockmeyer D, Tullous MW, Redone CA and Cawthon RM. (1992). Cancer Res., 52, 674-679.
4. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM and Dalla-Favera R. (1991). Proc. Natl. Acad. Sci. USA, 88, 5413-5417.
5. Hahn M, Serth J, Fislage R, Wolfes H, Allhof E, Jonas U and Pingoud A. (1993). Clin. Chem., 39, 549-550.
6. Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, Heldin C-H, Wiestler OD, Louis DN, von Deimling A and Nister M. (1996). Cancer Res., 56, 164-167.
7. Lang FF, Miller DC, Koslow M and Newcomb EW. (1994). J. Neurosurg., 81, 427-436.
8. Largey JS, Meltzer SJ, Yin J, Norris K, Sauk JJ and Archibald DW. (1993). Cancer, 71, 1933-1937.
9. Ledbetter SA, Kuwano A, Dobyns WB and Ledbetter DH. (1992). Am. J. Hum. Genet., 50, 182-189.
10. Louis DN and Gusella JF. (1995). Trends Genet., 11, 412-415.
11. Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH and Ali IU. (1992). Cancer Res., 52, 6716-6721.
12. Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong AJ and Godwin AK. (1996). Cancer Res., 56, 1997-2002.
13. Shapiro WR. (1986). Semin. Oncol., 13, 38-45.
14. Shaw EG, Sheithauer BW, Gilbertson DT, Nichols DA, Laws ER, Earle JD, Daumas-Duport C, O'Fallon JR and Dinapoli RP. (1989). Int. J. Radiat. Oncol. Biol. Phys., 16, 663-668.
15. von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Peterson I, Kleihues P, Chung RY, Wiestler OD and Seizinger BR. (1992). Cancer Res., 52, 2987-2990.
16. Wales MM, Biel MA, Deiry WE, Nelkin BD, Issa J-P, Cavanee WK, Kuerbitz SJ and Baylin SB. (1995). Nature Med., 1, 570-577.